MAP2K1 and Miyoshi myopathy: Interestingly, Pei et al. [42] reported that coexposure to the checkpoint kinase-1 (Chk1) and MEK1/2 inhibitors AZD7762 and selumetinib (AZD6244) robustly induced apoptosis in quiescent (G0/G1) MM cells.